Price $544.40 |
Market Cap
106.09B
|
Sector Health Care |
Div. Growth
15.10%
|
|
P/E
17.7
|
P/B
2.75
|
P/S
0.63
|
Dividend %
1.30%
|
|
P/CF
52.1
|
P/FCF
15.5
|
Op. Cash Flow
9.51M
|
FCF
28.9
|
|
Op. Margin
5.30%
|
Net Margin
3.60%
|
ROE
16.20%
|
ROI
11.40%
|
|
ROA
5.60%
|
EPS Growth
0.30%
|
Current Ratio
-
|
Debt/Equity
61.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Inotiv Inc (NOTV) | $1.44 | - | - | 46.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
